Outcome of transsphenoidal surgery for Cushing's disease: A high remission rate in ACTH-secreting macroadenomas

Clinical Neurology and Neurosurgery

Volumn 111, Issue 5, 2009, Pages 442-449

  Fomekong, Edward ^a   Maiter, Dominique ^a   Grandin, Cécile ^a   Raftopoulos, Christian ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

ACTH; Cushing's disease; Macroadenoma; Microadenoma; Neuronavigation; Transsphenoidal surgery

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE;

ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CUSHING DISEASE; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; INFERIOR PETROSAL SINUS; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; TRANSSPHENOIDAL SURGERY;

ACTH-SECRETING PITUITARY ADENOMA; ADOLESCENT; ADULT; AGED; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PITUITARY HORMONES; SPHENOID BONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349141548     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.12.011     Document Type: Article

References (44)

1. Arnaldi G., Angeli A., Atkinson A.B., Bertagna X., Cavagnini F., Chrousos G.P., et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88 (2003) 5593-5602
2. Boscaro M., Barzon L., Fallo F., and Sonino N. Cushing's syndrome. Lancet 357 (2001) 783-791
3. Newell-Price J. Transsphenoidal surgery for Cushing's disease: defining cure and following outcome. Clin Endocrinol (Oxf) 56 (2002) 19-21
4. Orth D.N. Cushing's syndrome. N Engl J Med 332 (1995) 791-803
5. Bochicchio D., Losa M., and Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 80 (1995) 3114-3120
6. Katznelson L., Bogan J.S., Trob J.R., Schoenfeld D.A., Hedley-Whyte E.T., Hsu D.W., et al. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab 83 (1998) 1619-1623
7. Blevins Jr. L.S., Christy J.H., Khajavi M., and Tindall G.T. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83 (1998) 63-67
8. Selvais P., Donckier J., Buysschaert M., and Maiter D. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. Eur J Endocrinol 138 (1998) 153-159
9. Barbetta L., Dall'Asta C., Tomei G., Locatelli M., Giovanelli M., and Ambrosi B. Assessment of cure and recurrence after pituitary surgery for Cushing's disease. Acta Neurochir (Wien) 143 (2001) 477-481 [discussion 481-472]
10. Cannavo S., Almoto B., Dall'Asta C., Corsello S., Lovicu R.M., De Menis E., et al. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol 149 (2003) 195-200
11. Chen J.C., Amar A.P., Choi S., Singer P., Couldwell W.T., and Weiss M.H. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98 (2003) 967-973
12. Hammer G.D., Tyrrell J.B., Lamborn K.R., Applebury C.B., Hannegan E.T., Bell S., et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab 89 (2004) 6348-6357
13. Nakane T., Kuwayama A., Watanabe M., Takahashi T., Kato T., Ichihara K., et al. Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery 21 (1987) 218-222
14. Carmalt M.H., Dalton G.A., Fletcher R.F., and Smith W.T. The treatment of Cushing's disease by trans-sphenoidal hypophysectomy. Q J Med 46 (1977) 119-134
15. Hofmann B.M., and Fahlbusch R. Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases. Front Horm Res 34 (2006) 158-184
16. Buchfelder M., and Fahlbusch R. Neurosurgical treatment of Cushing's disease in children and adolescents. Acta Neurochir Suppl (Wien) 35 (1985) 101-105
17. Dickerman R.D., and Oldfield E.H. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97 (2002) 1343-1349
18. Hofmann B.M., Hlavac M., Kreutzer J., Grabenbauer G., and Fahlbusch R. Surgical treatment of recurrent Cushing's disease. Neurosurgery 58 (2006) 1108-1118 [discussion 1108-1118]
19. Chee G.H., Mathias D.B., James R.A., and Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?. Clin Endocrinol (Oxf) 54 (2001) 617-626
20. McCance D.R., Besser M., and Atkinson A.B. Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 44 (1996) 1-6
21. McCance D.R., Gordon D.S., Fannin T.F., Hadden D.R., Kennedy L., Sheridan B., et al. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 38 (1993) 79-86
22. Sonino N., Zielezny M., Fava G.A., Fallo F., and Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 81 (1996) 2647-2652
23. Simmons N.E., Alden T.D., Thorner M.O., and Laws Jr. E.R. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 95 (2001) 1-8
24. Rees D.A., Hanna F.W., Davies J.S., Mills R.G., Vafidis J., and Scanlon M.F. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56 (2002) 541-551
25. Trainer P.J., Lawrie H.S., Verhelst J., Howlett T.A., Lowe D.G., Grossman A.B., et al. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 38 (1993) 73-78
26. Yap L.B., Turner H.E., Adams C.B., and Wass J.A. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin Endocrinol (Oxf) 56 (2002) 25-31
27. Gimenez-Palop O., Villabona C., Acebes J.J., Cabiol J., Torres Y., Gonzalbez J., et al. Early postoperative plasma adrenocorticotropin as a predictor of cure of Cushing disease. Endocrinologist 16 (2006) 163-167
28. Pereira A.M., van Aken M.O., van Dulken H., Schutte P.J., Biermasz N.R., Smit J.W., et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 88 (2003) 5858-5864
29. Rollin G.A., Ferreira N.P., Junges M., Gross J.L., and Czepielewski M.A. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. J Clin Endocrinol Metab 89 (2004) 1131-1139
30. Acebes J.J., Martino J., Masuet C., Montanya E., and Soler J. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease. Acta Neurochir (Wien) 149 (2007) 471-477 [discussion 477-479]
31. De Tommasi C., Vance M.L., Okonkwo D.O., Diallo A., and Laws Jr. E.R. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. J Neurosurg 103 (2005) 825-830
32. Mampalam T.J., Tyrrell J.B., and Wilson C.B. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 109 (1988) 487-493
33. Kristof R.A., Schramm J., Redel L., Neuloh G., Wichers M., and Klingmuller D. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas. Acta Neurochir 144 (2002) 555-561 [discussion 561]
34. Shimon I., Ram Z., Cohen Z.R., and Hadani M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51 (2002) 57-61 [discussion 61-52]
35. Pouratian N., Prevedello D.M., Jagannathan J., Lopes M.B., Vance M.L., and Laws Jr. E.R. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery. J Clin Endocrinol Metab 92 (2007) 3383-3388
36. Kelly D.F. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome. Neurosurg Focus 23 (2007) E5
37. Meij B.P., Lopes M.B., Ellegala D.B., Alden T.D., and Laws Jr. E.R. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96 (2002) 195-208
38. Hoybye C., Grenback E., Thoren M., Hulting A.L., Lundblad L., von Holst H., et al. Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases. J Neurosurg 100 (2004) 634-638
39. Knappe U.J., and Ludecke D.K. Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir Suppl 65 (1996) 31-34
40. Atkinson A.B., Kennedy A., Wiggam M.I., McCance D.R., and Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin Endocrinol (Oxf) 63 (2005) 549-559
41. Patil C.G., Prevedello D.M., Lad S.P., Vance M.L., Thorner M.O., Katznelson L., et al. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 93 (2008) 358-362
42. Patil C.G., Lad S.P., Harsh G.R., Laws Jr. E.R., and Boakye M. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus 23 (2007) E7
43. Esposito F., Dusick J.R., Cohan P., Moftakhar P., McArthur D., Wang C., et al. Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 91 (2006) 7-13
44. Semple P.L., and Laws Jr. E.R. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J Neurosurg 91 (1999) 175-179